1 / 1

MÓNICA HERNÁNDEZ ALAVA AND ALLAN WAILOO

MÓNICA HERNÁNDEZ ALAVA AND ALLAN WAILOO Health Economics and Decision Science, School of Health and Related Research ( ScHARR ), University of Sheffield, UK Email: m.hernandez@sheffield.ac.uk Web: www.shef.ac.uk/scharr/sections/heds/staff/hernandez_m.

idana
Download Presentation

MÓNICA HERNÁNDEZ ALAVA AND ALLAN WAILOO

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MÓNICA HERNÁNDEZ ALAVA AND ALLAN WAILOO Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield, UK Email: m.hernandez@sheffield.ac.uk Web: www.shef.ac.uk/scharr/sections/heds/staff/hernandez_m Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a limited dependent variable, mixture modelling approach • Introduction • Clinical trials often do not contain preference based outcome measure • Cost per QALY evaluation requires such outcomes • Linking clinical to preference based outcomes via statistical model is commonplace in economic evaluation • 22% of NICE appraisals include “mapping”, 100% in RA • Typically done using simple regression techniques • EQ-5D has an odd distribution • Standard methods perform badly • Develop and refine a new method here • Dataset • US not for profit observational database • 6 monthly assessments from adults with diagnosis of RA • N=103,867 from 16k patients • Methods • We have previously developed a bespoke statistical model for EQ-5D • Two key elements: • A distribution that is limited above at 1, below at -0.561 and has a gap between 1 and 0.883 • Mixture model – this is a blend of several different models, all based on the distribution in 1). • This approach provides a flexible statistical approach, that reflects the key features of EQ-5D. • Compare to the standard linear model • Using measures of fit and penalised likelihood • Simulated values from models compared to original data • All models estimate EQ-5D (UK tariff) as a function of HAQ, pain and other patient covariates Fig 1: Distribution of data Results Linear model – underestimates at top, overestimates at bottom 4 class mixture model – fits well across the range. Substantial improvement over linear model Simulations show linear model outside feasible range, mixture reflects distribution of original data Fig 2: Mean EQ-5D vs pain: observed and predicted Table 1: Comparison of model fit Fig 3: Simulations a-d) 4 components of mixture, e) mixture combined, f) linear model • Conclusions • Linear models are not appropriate for EQ-5D and lead to biased estimates of treatment benefits when used in economic evaluation. The bespoke mixture model is appropriate: • Better fit overall, no systematic bias, no prediction outside feasible range • More complex to fit, slightly more difficult to incorporate into CE model • But it matters! Example: • Mixture model: HAQ 0 to 2.5 = 0.57 QALY • NICE appraisals linear model = 0.82 QALY

More Related